(Q40369728)

19 September 2017

title

Expression analysis of 6p22 genomic gain in retinoblastoma (English)

1 reference

19 September 2017

1 reference

4

Brenda L Gallie

1 reference

19 September 2017

Marija Orlic

1

1 reference

19 September 2017

Clarellen E Spencer

series ordinal

2

1 reference

19 September 2017

Lisa Wang

series ordinal

3

1 reference

19 September 2017

publication date

1 January 2006

1 reference

Genes, Chromosomes and Cancer

19 September 2017

published in

1 reference

19 September 2017

volume

45

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

72-82

1 reference

Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction

19 September 2017

cites work

1 reference

Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene

21 January 2018

1 reference

Complex transcriptional regulatory mechanisms control expression of the E2F3 locus

21 January 2018

1 reference

7 January 2021

Transcriptional activation by AP-2alpha is modulated by the oncogene DEK

1 reference

7 January 2021

Phenotype variants, malignancy, and additional copies of 6p in retinoblastoma.

1 reference

7 January 2021

Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization

1 reference

7 January 2021

Solution NMR structure of the C-terminal domain of the human protein DEK.

1 reference

7 January 2021

Amplification and overexpression of E2F3 in human bladder cancer

1 reference

7 January 2021

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

1 reference

7 January 2021

Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization

1 reference

7 January 2021

Subcellular localization of the human proto-oncogene protein DEK

1 reference

7 January 2021

The identification of novel therapeutic targets for the treatment of malignant brain tumors

1 reference

7 January 2021

Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins

1 reference

7 January 2021

Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.

1 reference

7 January 2021

Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses

1 reference

7 January 2021

The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes

1 reference

7 January 2021

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

1 reference

7 January 2021

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner

1 reference

7 January 2021

A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

1 reference

7 January 2021

Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: Verification by standard staining techniques, new densitometric methods, and somatic cell hybridization

1 reference

7 January 2021

Structure-specific binding of the proto-oncogene protein DEK to DNA.

1 reference

7 January 2021

The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils

1 reference

7 January 2021

Retinoblastoma in transgenic mice

1 reference

7 January 2021

Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer

1 reference

7 January 2021

Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20263

1 reference

19 September 2017

1 reference